SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review
Michael Dwinata, David Dwi Putera, Irsan Hasan, Monica Raharjo
Research output: Contribution to journal › Article › peer-review
29Citations
(Scopus)
Fingerprint
Dive into the research topics of 'SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review'. Together they form a unique fingerprint.